However, the same mice when examined at 9–12 months showed accelerated progression of cancer and tumor formation, suggesting that long-term Pontin inhibition may pose unforeseen risks in vivo (Bereshchenko et al., 2012). Here, RUVBL1 is linked to neoplasm.